Artimplant applies for its own bankruptcy The Board of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Artimplant applies for its own bankruptcy

The Board of Directors and the CEO of Artimplant AB (publ) have decided to apply for its own bankruptcy. The reasons behind the insolvency and the liquidity problems are related to the ongoing litigations in the USA, where Artimplant has been sued by approx. 50 patients who claims they have been injured by the CMC Spacer, and the ongoing Arbitration in Sweden, which has been initiated by Artimplant to determine which insurance company or insurance broker are responsible for each claim related to the litigations in the USA. The ongoing disputes have had a negative impact on Artimplants sales and have also occupied the management’s recourses which have resulted negatively on the company’s development. Parallel to this there has been an intensive work to try to find a new main shareholder, attract new capital to the company and to find new improved distribution channels. The Board has been in discussions with potential investors and other interested parties but the ongoing disputes substantially reduced the interested to invest in the company. The Board has also discussed a possible new right issue of shares but during the current circumstances decided this will not be possible to achieve. Taking all this into consideration it has not been possible to fulfil the earlier signed agreement with Tiller. The Board and the CEO has therefore reached the conclusion to apply for Artimplants bankruptcy. Västra Frölunda, August 1, 2013 The Board of Directors For additional information, please contact: Håkan Johansson, Chairman of the board, phone +46 (0)705 14 21 57 Kjell Thörnbring, CEO, phone +46 (0)703 11 90 25, kjell.thornbring@artimplant.com Artimplant Artimplant is a biomaterials company focused on solutions to problems in orthopedic. We restore health through the development, production and marketing of degradable implants that regenerate body functions and improve quality of life. Our products, made from Artelon®, meet unmet clinical needs and are marketed in a growing number of therapy areas. Artimplant produces implants for treatment of osteoarthritis in hands and feet, for shoulder and other soft tissue injuries. Artimplant is a public company listed on the OMX Nordic Exchange Stockholm in the Small Cap segment and in the healthcare sector. Forward-looking statements This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting the Company's business including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks detailed from time to time in the Company's filings. This is information which Artimplant shall make public pursuant to the Swedish Financial Instruments Act and the Swedish Securities Exchange and Clearing Operations Act and/or stock market agreements. Information was made available for publication on August 1, 2013 at 8:45 AM (CET).

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 1

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 3

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 2

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 2

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 7

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 2

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 2

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 3

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 2

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading

Top 5 Most Recently Viewed Articles

Unitree Robotics: Kung Fu Meets Spring Gala Innovation

Updated Category News Views 235

On February 17, 2026, Unitree Robotics stole the show at China's Spring Festival Gala, presenting groundbreaking humanoid robotics that set multiple world records in motion performance. The G1 and H2 models executed a fully autonomous martial arts routine that had traders buzzing about potential applications across industries. This isn't just another tech showcase; it's a...

Continue Reading
FORVIA's Strategic Move: Early Redemption of Note Obligations

Updated Category News Views 82

FORVIA's Early Redemption Strategy FORVIA has made a significant announcement regarding its financial strategies by proactively engaging in the early redemption of €200 million worth of its €700 million 3.750% notes that are due in 2028. This decision highlights the company's commitment to enhancing its financial structure and showcases a strategic move that many...

Continue Reading
Yutong Bus Revolutionizes Vehicle Service with EnRoute+ Launch

Updated Category News Views 590

Yutong Bus Revolutionizes Vehicle Service with EnRoute+ Launch Six-Point Service Framework Elevates Efficiency and Customer Value Yutong Bus, a leading commercial vehicle manufacturer, recently debuted its EnRoute+ service platform to reshape the standards of vehicle support in the industry. This innovative initiative aims to transition operators away from a mere...

Continue Reading
Charter Communications' Q3 Performance: Breaking Records with Mobile Growth

Updated Category News Views 100

Charter Communications' Quarterly Performance Overview Charter Communications Inc (NASDAQ: CHTR) has shared its fiscal third-quarter results, revealing a revenue growth of 1.6% from the previous year, totaling $13.8 billion. This figure surpasses analysts' expectations, which projected the revenue to hit approximately $13.7 billion. Outstanding Earnings Per Share and...

Continue Reading
Understanding American Airlines' Stock and Its Value Trends

Updated Category News Views 435

Insight into American Airlines' Stock Performance Currently, American Airlines Gr Inc. is trading at $17.29, reflecting a modest increase of 0.23% in today’s session. In the past month, this stock has surged by an impressive 18.51%, and when observing the past year, the growth stands at 24.02%. Such figures bring hope to long-term investors, sparking curiosity among...

Continue Reading